ESR1 and cancer: Within the hormonal background associated with this type of cancer, about 75% of patients suffering from this disease are clinically diagnosed with estrogen receptor-positive (ER+) tumors; thus, in both basic and clinical research, regulating ER expression becomes pivotal [8].